Patent and Exclusivity Expirations Report

Report generated for the week of 2025-08-11 by Unibest Digital Center. Current analysis scope only include the US FDA.

Visit Unibest Licensing serivce and explore FDF assets open for global licensing and/or technology transfer.

Visit Unibest intermediates and APIs for global supply.

Summary of Expirations

This week, there are 6 drugs in the patent and exclusivity list. They are:

Ozempic by Novo Nordisk Inc, containing active ingredient Semaglutide

Victoza by Novo Nordisk Inc, containing active ingredient Liraglutide

Saxenda by Novo Nordisk Inc, containing active ingredient Liraglutide

Viltepso by Nippon Shinyaku Co Ltd, containing active ingredient Viltolarsen

Kalydeco by Vertex Pharmaceuticals Inc, containing active ingredient Ivacaftor

Lenvima by Eisai Inc, containing active ingredient Lenvatinib Mesylate

Patents Expiring This Week

Report generated for the week of 2025-08-11 by Unibest Digital Center. Current analysis scope only include the US FDA.

Visit Unibest Licensing serivce and explore FDF assets open for global licensing and/or technology transfer.

Visit Unibest intermediates and APIs for global supply.